期刊文献+

2020~2022年贵州省临床实验室常规生化项目应用批长度Westgard西格玛规则的室内质量控制策略分析 被引量:2

Analysis of Internal Quality Control Strategies for the Application of Batch Length Westgard Sigma Rules in Routine Biochemical Projects of Clinical Laboratories in Guizhou Province from 2020 to 2022
在线阅读 下载PDF
导出
摘要 目的了解2020~2022年贵州省常规生化项目室内质量控制(internal quality control,IQC)情况,并运用分析批长度西格玛规则为常规生化项目选择恰当的IQC策略。方法从参加2020~2022年贵州省临床检验中心常规生化项目第一次室间质量评价(external quality assessment,EQA)计划的实验室中筛选出统一采用英国朗道公司生产的两个浓度水平室内质控品的41家、41家和52家实验室,根据其IQC信息计算变异系数(coefficient of variation,CV),将CV与WS/T403-2012标准等不精密度性能规范进行比较,分析近年来贵州省常规生化项目的IQC情况;每年从中随机抽取15家回报三酰甘油项目结果的实验室并计算σ值,根据分析批长度Westgard西格玛规则流程图为其选择合适的质控策略,计算质量目标指数(quality goal index,QGI)以评价各实验室检测系统的分析性能。结果当月CV中,Ca,TP 2个项目满足WS/T403-2012标准的实验室比例较低,而P,CK,LDH等7个项目通过率均在80%以上,且呈逐年上升趋势;P,CK,LDH等7个项目符合生物医学变异(适当)性能规范的实验室比例均达90%,但Na,Ca,Cl等5个项目比例较低。累积CV中P,CK,LDH等10个项目满足生物医学变异(适当)性能规范的实验室比例在90%以上。对于三酰甘油项目,2020年~2022年分别有2家、5家、13家实验室达到6σ水平;与2020年和2021年相比,2022年σ值变化趋势上升(t=3.855,3.511,P≤0.001),表明这些实验室分析性能越来越好。结论贵州省部分常规生化项目的IQC水平在逐年提升。分析批长度Westgard西格玛规则为贵州省各实验室设计个性化质控规则,提高实验室的检测能力,更好地服务临床。 Objective To understand the internal quality control(IQC)situation of routine biochemical projects in Guizhou Province from 2020 to 2022,and to use the analysis batch length sigma rule to select the appropriate IQC strategy for routine biochemical projects.Methods A sum of 41,41 and 52 laboratories were selected from the laboratories participating in the first external quality assessment(EQA)program of the routine biochemical project in the Guizhou Provincial Center for Clinical Laboratory from 2020 to 2022,which uniformly used two concentration levels of internal quality control products produced by Randox Company in the UK.The coefficient of variation(CV)was calculated based on their IQC information,and then these CV values were used to compare with imprecise performance specifications such as WS/T403-2012 standards.The IQC situation of routine biochemical projects of Guizhou Province in recent years was analyzed.Randomly 15 laboratories were selected each year to report the results of the triglyceride project,and theirσvalues were calculated.Based on the Westgard sigma rule flowcharts of the analysis batch length,appropriate quality control strategies were selected and the quality goal index(QGI)was calculated to evaluate analytical performance of laboratory detection system.Results In the current monthly CV,the proportion of laboratories that met the WS/T403-2012 standards for Ca and TP projects was relatively low,while the pass rates for 7 projects(P,CK,LDH and other projects)were all above 80%,showing an increasing trend year by year.The proportion of laboratories with the 7 projects(P,CK,LDH and other projects)meeting the performance specifications for biomedical variation(appropriate)all reached 90%,while the proportion of laboratories with 5 projects(Na,Ca,Cl and other projects)was relatively low.The proportion of 10 projects such as P,CK,and LDH in cumulative CV of laboratories that met the performance specifications for biomedical variation(appropriate)was over 90%.For the triglyceride project,from 2020 to 2022,there were 2,5 and 13 laboratories that reached 6σhorizontal.Compared to values of 2020 and 2021 years,the trend ofσvalues changes of 2022 was increasing(t=3.855,3.511,P≤0.001),indicating that the analytical performance of these laboratories was getting better and better.Conclusion The IQC levels of routine biochemical projects in Guizhou Province were increasing year by year.The Westgard sigma rule of the analysis batch length is designed with personalized quality control rules for various laboratories in Guizhou Province,thus improving laboratory testing capabilities and better severing clinics.
作者 张淑俊 袁薇 孙建超 杨敬源 李梅 张娜佳 ZHANG Shujun;YUAN Wei;SUN Jianchao;YANG Jingyuan;LI Mei;ZHANG Najia(School of Public Health,the Key Laboratory of Environmental Pollution Monitoring and Disease Control,Ministry of Education Guizhou Medical University,Guiyang 561113,China;Guizhou Provincial Clinical Laboratory,Guiyang 550002,China;Guizhou Provincial Center for Disease Control and Prevention,Guiyang 550004,China)
出处 《现代检验医学杂志》 CAS 2024年第2期184-191,共8页 Journal of Modern Laboratory Medicine
基金 贵州省卫健委科技基金项目(gzwjkj2020-1-198):基于地理信息系统的贵州肺结核时空分析研究。
关键词 室内质量控制 Westgard西格玛规则 质量目标指数 质控规则 internal quality control Westgard sigma rules quality goal index quality control rules
作者简介 张淑俊(1999-),女,硕士在读,研究方向:室内质量控制,E-mail:1923905931@qq.com;通讯作者:袁薇(1973-),女,硕士,主任技师,研究方向:病原微生物,E-mail:64692857@qq.com。
  • 相关文献

参考文献17

二级参考文献73

  • 1史继雷,赵志文,曹吉斌,邢树娟.脑脊液生化指标与临床的关系[J].医学检验与临床,2002,14(3):39-32. 被引量:3
  • 2张秀明,郑松柏,孙蕾,柯培锋,马骥,张文,林莲英.应用Westgard方法评价决定图判断生化检测系统性能的可接受性[J].中华检验医学杂志,2007,30(1):86-90. 被引量:73
  • 3李园园,李萍,黄亨建.应用六西格玛理论评价临床实验室检验性能及设计质控方案[J].中国医疗器械信息,2007,13(6):9-11. 被引量:36
  • 4Westgard JO. A method evalouation decision chart (MEDx char)for judging method performance[J].Clinical Laboratory Science,1995.277-283.
  • 5Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ)[J].Journal of the American Medical Association,2001.2486-2497.
  • 6Klee GG. Establishment of outcome-related analytic performance goals[J].Clinical Chemistry,2010.714-722.
  • 7中华人民共和国国家质量监督检验检疫总局;中国国家标准化管理委员会.临床实验室定量测定室内质量控制指南[M],2006.
  • 8Clinical and Laboratory Standards Institute. User Verification of Performance for Precision and Trueness; Approved Guideline[S].Wayne,PA:CLSI,2004.
  • 9Skitek M. Acceptability limits based on biology goals in haematology EQAS[J]. Accred Qual Assur, 2005, 10:112-115.
  • 10Westgard JO. A method evaluation decision chart (MEDx char)for judging method performance [ J ]. Clin Lab Sci, 1995,8 (5) : 227- 283.

共引文献128

同被引文献19

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部